Document is current
Any future updates will be listed below
-
Authors
Paixao, Enny S. https://orcid.org/0000-0002-4797-908X
Wong, Kerry L. M.
Alves, Flavia Jôse Oliveira
de Araújo Oliveira, Vinicius
Cerqueira-Silva, Thiago
Júnior, Juracy Bertoldo
Machado, Tales Mota
Junior, Elzo Pereira Pinto
Boaventura, Viviane S.
Penna, Gerson O.
Werneck, Guilherme Loureiro
Rodrigues, Laura C.
Pearce, Neil
Barreto, Mauricio L.
Barral-Netto, Manoel
-
Funding
Funding for this research was provided by:
Wellcome Trust (213589/Z/18/Z)
Fazer o bem faz bem
- License Information
-
More Information
Article History
Received: 26 November 2021
Accepted: 24 March 2022
First Online: 5 April 2022
Declarations
:
: This study was approved by the National Ethics committee (CONEP) (CAAE registration no. 50199321.9.0000.0040).
: Not applicable.
: The authors declare that they have no competing interests. VO, VB, MB, and MB-N are employees from Fiocruz, a federal public institution, which manufactures Vaxzevria in Brazil, through a full technology transfer agreement with AstraZeneca. Fiocruz allocates all its manufactured products to the Ministry of Health for the public health service (SUS) use.
